Quhill, F.; Beiderbeck, A. Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN®) Versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema. Grhta 2017, 4, 155-164.